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Abstract 
 3D bioprinting is a novel platform for engineering complex, three-dimensional (3D) tissues that 
mimic real ones. The development of hybrid bioinks is a viable strategy that integrates the desirable 
properties of the constituents. In this work, we present a hybrid bioink composed of alginate and cellulose 
 
 
2 
 
nanocrystals (CNCs) and explore its suitability for extrusion-based bioprinting. This bioink possesses 
excellent shear-thinning property, can be easily extruded through the nozzle, and provides good initial 
shape fidelity. It has been demonstrated that the viscosities during extrusion were at least two orders of 
magnitude lower than those at small shear rates, enabling the bioinks to be extruded through the nozzle 
(100 μm inner diameter) readily without clogging. This bioink was then used to print a liver-mimetic 
honeycomb 3D structure containing fibroblast and hepatoma cells. The structures were crosslinked with 
CaCl2 and incubated and cultured for 3 days. It was found that the bioprinting process resulted in minimal 
cell damage making the alginate/CNC hybrid bioink an attractive bioprinting material. 
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Introduction: 
3D printing, otherwise known as additive manufacturing, is a term used to describe the process of 
fabricating a three-dimensional (3D) object layer by layer.1,2 3D bioprinting is a subset of 3D printing, 
which dispenses bioinks to construct complex 3D tissue architecture.3 It allows for recapitulations of cell-
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cell and cell-extracellular matrix (ECM) interactions that are absent in conventional two-dimensional (2D) 
in vitro cell culture but are crucial in modulating cellular behavior found under in vivo conditions. 4 The 
most commonly used bioprinting techniques are extrusion-based, particle fusion-based, light-induced, and 
inkjet-based bioprinting.1–3,5–9 Extrusion-based bioprinting is one of the most popular techniques due to 
compatibility with a variety of bioink, ease of operation and relatively low cost. 3,10 Among various 
bioinks, hydrogels represent a class of promising materials because they provide a highly hydrated, 
biocompatible, 3D environment.11–13 
Generally, a bioink should satisfy three requirements for extrusion-based bioprinting. First, the 
bioink should possess shear-thinning property, which ensures facile extrusion through a pressurized 
nozzle and good initial shape fidelity after extrusion.13–17 Second, the bioink should have sufficient 
mechanical strength to support the bioprinted structure and retain its shape.7 Third, the bioink should 
protect the encapsulated cells from mechanical stress during printing.18 
Alginate is a natural polymer that has been extensively studied as a hydrogel material for tissue 
engineering applications due to its favorable properties, such as biocompatibility and easy 
processability.19–21 Upon exposure to divalent cations such as Ca2+, alginate undergoes a rapid and robust 
gelation process where the polymer chains form an “egg-box structure” with the divalent ions. 22,23 
However, the rheological properties of pure alginate result in poor printability and pattern fidelity, which 
greatly limits its use in 3D bioprinting. 14,24   
Cellulose nanocrystals (CNCs) are rod-like or whisker-shaped nanoparticles extracted from the 
crystalline regions of cellulose fibers. In recent decades, its numerous favorable properties (e.g. 
renewability, low density, high mechanical strength, large and highly reactive surfaces, and low 
cytotoxicity) have attracted a significant amount of research interests for a variety of applications, 
including tissue engineering.25–29 CNC can be mixed into various polymer matrices to reinforce the 
mechanical strength and induce shear thinning behavior.28,30,31 For example, Siqueira et al. developed a 
hybrid ink comprising of CNC, 2-hydroxyethyl methacrylate (HEMA) monomer and polyether urethane 
acrylate (PUA). They found that the CNC particles align along the printing direction by shear flow, and 
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the CNC inks display shear-thinning behavior.32 Hence, CNC is a suitable additive for enhancing the 
shear-thinning property of bioink. 
In this work, we prepared a hybrid bioink by blending alginate and CNC, which combines the 
desirable properties and overcomes the inherent disadvantages of the individual components. Rheological 
properties such as shear-thinning, extrudability, and shape fidelity were investigated. An optimized bioink 
formulation was then selected to print a liver-mimetic 3D honeycomb structure, which was cultured with 
fibroblasts and hepatoma cells. It has been demonstrated that viability of cells encapsulated in this bioink 
is unaffected during printing.  
Materials and Methods 
Materials 
Pharmaceutical grade sodium alginate (PROTANAL LF 10/60 FT) containing 60-70% G residues 
was acquired from FMC (Philadelphia, PA). CNC hydrolyzed from wood was supplied by Celluforce Inc. 
Phosphate-buffered saline was purchased from EMD Chemicals (Darmstadt, Germany). Calcium chloride 
was purchased from Sigma-Aldrich (St. Louis, Missouri). NIH/3T3 Fibroblast and human hepatoma cells, 
Eagle’s Minimum Essential Medium (EMEM) and penicillin/ streptomycin were purchased from ATCC 
(Manassas, VA). Dulbecco’s Modified Eagle’s Medium (DMEM) and trypsin/EDTA solution were 
obtained from Lonza (Walkersville, MD). Fetal bovine serum (FBS) and trypan blue stain (0.4%) were 
provided by Gibco (Carlsbad, CA). LIVE/DEAD viability/cytotoxicity kit was purchased from Life 
Technologies (Carlsbad, CA).  
Bioink Preparation 
Dry CNC powder was dispersed in Milli-Q water to prepare 2, 4, 6, and 8% (w/v) CNC solutions. 
Similarly, dry alginate powder was weighed and dissolved in Milli-Q water to prepare 4% (w/v) and 6% 
(w/v) alginate solutions. To prepare the alginate/CNC hybrid pre-gel solutions, equal volumes of CNC 
and alginate solutions were mixed. Seven formulations of bioinks with different ratios of alginate and 
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CNC as listed in Table 1 were prepared. The pre-gel solution was sterilized by autoclaving at 121 ℃ for 
20 min for cell culture. 
Rheological Properties of the Hybrid Bioinks 
The rheological properties of the inks were analyzed using a Bohlin-CS Rheometer with a cup 
and bob geometry (C25, bob diameter of 25mm and gap width of 150 µm). All measurements were 
conducted at room temperature.  
Determination of Shear-Thinning 
Using a constant rate testing mode, the steady-state shear viscosities of pure alginate (20/00, 
40/00, and 60/00), and hybrid bioinks (20/10, 20/20, 20/30, and 20/40) were conducted over a range of 
shear rate of 0.1-500 s-1.  
Determination of Shear Rate 
Power-law index (n) was calculated by curve-fitting the viscosity vs. shear rate curves using the 
power-law model: 
    ̇    (1) 
where K is the consistency, η is the viscosity, and  ̇ is the shear rate. The shear rate at the nozzle wall can 
be obtained from the equation: 
 ̇  
  
   
(
 
 
 
 
  
) (2) 
 where Q is the volumetric flow rate (16 µL/s) and r is the nozzle radius (50 µm).  
 Determinations of elastic and viscous moduli 
A strain sweep from 0.05% to 10% was performed at a frequency of 1 Hz to determine the linear 
viscoelastic region (LVR). Subsequently, an optimized LVR strain of 0.1% was chosen for the oscillation 
frequency measurements performed from 0.1 to 10 Hz. The frequency sweeps were then used to define 
the elastic modulus (G’) and the viscous modulus (G’’). 
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 Printability of Hybrid Bioinks 
A designed syringe holder was printed in polylactic acid (PLA) using the thermoplastic extruder on a 
FlashForge Creator Pro (FlashForge, China). The original thermoplastic extruder from the x-axis carriage 
was then removed and replaced with the custom-made syringe holder. The modified FlashForge Creator 
Pro’s operation software was unaltered, except for manual settings such as nozzle diameter, filament 
diameter, and extrusion temperature. Liver mimetic honeycomb models (1.75 mm spacing, 0.48 mm wall 
thickness, and 1.2 mm wall height as shown in Figure 1) were designed using Solidworks software and 
saved as an STL file. This file was then converted to G-code using ReplicatorG. The bioink-loaded 
syringe was equipped with a 32-gauge disposable tip (EFD Nordson, USA) and was fitted onto the plastic 
syringe holder. Applied extruding pressure ranged from 5 to 25 psi to control the ink flow rate to match 
the moving speed of the nozzle at 25 mm s-1. The bioinks were deposited in 16 layers. 
Morphologies of Hydrogels 
 The structures of hydrogel samples (20/00 and 20/40) were characterized using a field emission 
scanning electron microscope (FE SEM, Zeiss Leo 1530). The samples were first prepared in a custom-
made Teflon mold and immersed in a 1% (w/v) CaCl2 bath. The crosslinked hydrogels were instantly 
frozen in liquid nitrogen and lyophilized before being cut into small pieces with a sharp blade. The 
samples were then deposited onto an aluminum holder which was placed in a sputter coater, coating 
samples with a thin layer of gold. The pore size was analysed using ImageJ software. 
3D Bioprinting of Liver-mimetic Tissue Constructs 
Cell Culture 
Fibroblasts were cultured in complete DMEM supplemented with 10% FBS and 100 unit/mL 
penicillin, 100 µg/mL streptomycin. Human hepatoma cells were cultured in EMEM with 10% FBS and 
100 unit/mL penicillin, 100 µg/mL streptomycin. Both cell lines were maintained in a 5% CO2 incubator 
at 37 ℃.  
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Bioprinting 
For the construction of liver-mimetic structures, the outer honeycomb structures were first printed 
using one syringe with fibroblast-containing bioinks (106 cells/mL) using the aforementioned printing 
protocol. The inner cavities with a diameter of 1.5 mm were then printed using another syringe with 
bioink containing human hepatoma cells (106 cells/mL). The printed constructs were gelated in 1% (w/v) 
CaCl2 solution for 10 min and then washed with serum-free DMEM. Next, the constructs were cultured in 
complete DMEM supplemented with 5 mM CaCl2 in an incubator. Molded constructs were made as 
control samples using an extrusion-free method. Briefly, 20/40 bioink containing fibroblasts or hepatoma 
cells was placed on a sterilized glass slide with two spacers (150 µm thickness) and covered with an ion 
permeable membrane to make a slab (26 mm×26 mm×0.15 mm), which was then immersed in 1% (w/v) 
CaCl2 for 10 min and was cultured in the same condition as that of the honeycomb constructs.  
Cell Viability Studies 
Viability of naked cells was assessed on day 0 using trypan blue stain and a hemocytometer. A 
LIVE/DEAD viability/cytotoxicity kit was utilized to determine the cell viability within the molded and 
bioprinted constructs on days 0, 1, and 3. Calcein-AM/ethidium homodimer was diluted in serum-free 
DMEM with ratios of 1: 2000 and 1: 500, respectively. The samples were first washed with serum-free 
DMEM for 10 min and then incubated in the staining solution for 2 hours. Afterwards, the samples were 
washed with serum-free medium for another 10 min. A fluorescence microscope (Nikon Eclipse Ti-S) 
was used to image the live and dead cells within the constructs. Images from each sample were taken and 
analyzed using ImageJ software. Cell viability was calculated by dividing the number of live cells by the 
total numbers of cells in the constructs. 
Statistical analysis 
All data were presented as mean ± standard deviation. Differences between samples were 
determined from the independent t-test and were considered statistically significant when p < 0.05.  
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Results and Discussion 
Fabrication of Molded and Bioprinted Constructs 
The overview of the sample fabrication process is illustrated in Figure 1. In brief, fibroblast and 
human hepatoma cells were trypsinized and added to the bioink, and the cell-laden bioink was either 
extruded through a nozzle for bioprinting or molded into a slab. The printed constructs and molded slabs 
were then further gelated by crosslinking the alginate chains in a CaCl2 bath, followed by culturing in a 
CaCl2-supplemented medium. The CNC used is produced by Celluforce Inc. with lengths of 200-400 nm 
and diameters of 10-20 nm as shown in Figure 2A. The CNC is derived from sulfuric acid hydrolysis with 
abundant negatively charged sulfate groups on the surface. 
 
 
Rheological Properties of Hybrid Bioinks 
Determination of Shear-Thinning. Figure 2B and Figure S1A show the viscosity vs. shear rate 
curves for all bioink formulations. It was found that despite higher viscosity associated with higher 
concentration, the curves for pure alginate (20/00, 40/00, and 60/00) all appeared to be relatively flat, 
suggesting that pure alginate has minimal shear-thinning property and is not suitable for bioprinting. On 
the other hand, the curves for hybrid bioinks were steep, where the addition of CNC greatly enhances 
shear-thinning property. A possible reason for the shear-thinning behavior is that alginate and CNC 
molecules are entangled randomly at static state, but re-aligned when shear stress is applied, thus 
lowering the viscosity of bioink (Figure 2C). In addition, the flow curves of the 2% (w/v) alginate bioinks 
converged as shear rate increased, indicating the addition of CNC does not have much effect on the 
viscosity of hybrid bioink at high shear rates. Moreover, after cells were suspended in the bioink at a 
concentration of 106 cells/mL, no significant changes in viscosity during extrusion were observed (Figure 
S2).  
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Determination of Shear Rate 
Table 2 shows the power law index (n) and the shear rate values for bioinks containing 2% (w/v) 
alginate. All of the hybrid bioinks had n values that were smaller than 1, further confirming that the 
addition of CNC enhances the shear-thinning property. The shear rate exerted on the hybrid bioinks was 
approximately 200-300 s-1, where the viscosities were at least two orders of magnitude lower than those at 
small shear rates, enabling the bioink to be readily extruded through the nozzle (100 µm inner diameter) 
with no clogging.  
Determinations of Elastic and Viscous Moduli 
Frequency sweeps at 0.1% strain measuring the elastic modulus (G’) and viscous modulus (G’’) 
of different formulations are shown in Figure 2D and Figure S1B. For all pure alginate bioinks, G’’ 
values were higher than G’ values over the frequency range, indicating that they are liquid-like. Hence, 
pure alginate gives poor shape fidelity and is not suitable for 3D bioprinting. On the other hand, the G’ 
values were higher than G’’ values for all hybrid bioinks, suggesting that hybrid pre-gel solutions are 
solid-like and they can provide good shape fidelity after extrusion.  
 
Printability of Hybrid Bioninks 
To evaluate the printability of the hybrid bioinks (20/10, 20/20, 20/30, and 20/40), they, along 
with 20/00, were loaded to print a liver-mimetic 3D honeycomb structure (Figure 3). As concentration of 
CNC increased, the geometries of the printed structure became increasingly well-defined, with 20/40 
exhibiting the highest printing accuracy. Thus, 20/40 was selected as the best candidate for bioprinting. 
 
Morphological Characterizations 
SEM was employed to visualize the detailed pore structure with the 20/00 and 20/40 hydrogels 
and investigate the effect of CNC on the microstructure of the hybrid gel. The SEM micrograph of the 
pure alginate hydrogel showed a porous structure with wide-ranging microsized pores (7-178 µm; Figure 
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4A). On the other hand, the incorporation of CNC in the alginate network resulted in a highly porous 
microstructure with more uniform pores being ~20 µm in size (Figure 4B). The smooth surface of the 
pore walls of the hybrid hydrogels indicated the absence of CNC aggregation, suggesting that the CNCs 
were homogeneously dispersed in the alginate-based hydrogels matrix.  
 
Cell Viability Studies 
A 3D liver-mimetic honeycomb structure was designed as shown in Figure 5A. Figure 5B shows 
an image of the 3D structure immediately after bioprinting. Green and purple food dyes were utilized to 
differentiate the fibroblast-laden bioink (green) from the human hepatoma cells-laden bioink (purple). 
The viabilities of naked (before mixing with bioink) fibroblast and hepatoma cells were 96.47% and 
92.75%, respectively. On day 0, the cell viabilities of the molded constructs were 70.73% for fibroblast 
and 55.07% for hepatoma, which could be attributed to mechanical stress during mixing and possibly the 
cytotoxicity of CaCl2. The cell viabilities of fibroblast and hepatoma cells in bioprinted constructs on day 
0 were 71.00% and 67.06%, respectively.  No significant differences in cell viability were observed 
between molded and bioprinted constructs, indicating that the bioprinting process resulted in no 
observable cell death and thus is cell-compatible. However, after 3 days, cell viabilities of fibroblast and 
hepatoma cells decreased to 58.91% and 49.51%, respectively (Figure 5C). The declining viability over 
time may arise from the lack of cell-binding sites in the hydrogel, which limit cell adhesion, viability and 
proliferation. To circumvent such issue, one potential solution is incorporating polymers containing cell-
binding sites, such as gelatin, into the system. There is an ever-growing amount of evidence reported in 
research literature that gelatin is effective in promoting the cell attachment due to its RGD tripeptide 
sequences, which are the major integrin-binding domains present within extracellular matrix (ECM).33,34 
Our preliminary results (Figure S4) show that the incorporation of gelatin in the alginate-CNC hybrid 
bioink does not influence the viscosity and hence printability of the bioink. Figures 5D-E show the 
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fluorescence images of homogeneously distributed fibroblasts and human hepatoma cells in the bioprinted 
constructs. 
 
Conclusions 
In this work, we developed a hybrid bioink by blending alginate with CNC. This bioink displayed 
excellent shear-thinning property, extrudability, and shape fidelity after deposition. The 20/40 (2% 
alginate and 4% CNC) bioink formulation was selected to print a liver-mimetic honeycomb 3D structure 
containing fibroblast and heptatoma cells, and the bioprinting process was found to induce minimal cell 
death. Overall, the proposed bioink has good potential for 3D bioprinting. 
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Figure 1. Schematic illustration of the fabrication process. 
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Figure 2. (A) TEM image of CNC used in this study. (B) Flow curves of five different bioink 
formulations, 20/00, 40/00, 60/00, 20/20, and 20/40. (C) Schematic illustration of interactions between 
alginate (grey) and CNC (green) at static state and under shear stress (τ). At static state (left), alginate and 
CNC are entangled in the hybrid solution randomly, while under shear stress (right), entangled alginate 
and CNC align. (D) Elastic modulus (G’) and viscous modulus (G’’) of three representative bioink 
formulations 20/00, 60/00, and 20/40 as a function of oscillatory frequency.  
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Figure 3. Optical images of 3D printed constructs using bioink formulations (A) 20/00, (B) 20/10, (C) 
20/20, (D) 20/30, and (E) 20/40, respectively. (F) The zoomed-in image of the outlined area in (E). Scale 
bars are 5 mm in (A-E) and 500 μm in (F).  
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Figure 4. Scanning electron micrographs of freeze-dried (A) alginate (20/00) and (B) alginate/CNC 
(20/40) hydrogels. 
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Figure 5. (A) Schematic top-down view of the liver-mimetic engineered tissue constructs. (B) 3D printed 
constructs with bioink 20/40. Food dyes were used to distinguish fibroblast-laden bioink (green) from 
hepatoma cell-laden bioink (purple). (C) Statistical analysis of viabilities (live cells populations/total cell 
populations) of fibroblast and human hepatoma cells on days 0, 1, and 3. (D&E) Representative live/dead 
fluorescent images of bioprinted (D) fibroblast only and (E) fibroblast plus human hepatoma cells. The 
dashed lines are the boundaries of the designed structure. The cells were stained with Calcein-AM and 
ethidium homodimer-1 to show live (green) and dead (red) cells. Scale bars are 5 mm in (B) and 250 μm 
in (D) and (E). 
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Table 1. Summary of bioink formulations. 
 
 
 
 
 
  
Bioink formulation 
Alginate 
(% w/v) 
CNC 
(% w/v) 
Water content 
(% w/v) 
20/00 2 0 98 
20/10 2 1 97 
20/20 2 2 96 
20/30 2 3 95 
20/40 2 4 94 
40/00 4 0 96 
60/00 6 0 94 
 
 
19 
 
Table 2. Power-law index (n), shear rate ( ̇), and viscosity (η) for bioinks containing 2% (w/v) alginate 
plus 0 %, 1 %, 2%, 3%, and 4% (w/v) CNC 
Ink formula n  ̇  (s
-1) ηw (Pa s) τw (Pa) 
20/00 0.697 180 0.245 44.1 
20/10 0.559 195 0.345 67.3 
20/20 0.271 272 0.266 72.4 
20/30 0.247 287 0.341 97.9 
20/40 0.225 303 0.551 166.9 
 
 
 
 
 
 
 
 
